Revolutionary Shift: How Sonnet BioTherapeutics Became a $305M Digital Asset Treasury Powerhouse
In a move that signals a seismic shift in corporate strategy, a Nasdaq-listed biotech firm has just voted to transform its entire future..
In a move that signals a seismic shift in corporate strategy, a Nasdaq-listed biotech firm has just voted to transform its entire future..